SCHEMBL6404536

SCHEMBL6404536

Cn1c(Cc2ccccc2)nnc1SCc1ccccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
HPGD P15428 3/20 0.61
HTT P42858 2/20 0.61
GAA P10253 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
HSD17B10 Q99714 3/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MAPT P10636 2/20 0.52
KMT2A Q03164 3/20 0.52
PKM P14618 3/20 0.52
MEN1 O00255 2/20 0.52
HSP90AA1 P07900 1/20 0.52
MAPK1 P28482 2/20 0.51
APOBEC3A P31941 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
POLB P06746 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14779109 0.88 RAB9A (0.55) ALDH1A1HPGDHTTGAANPSR1
SCHEMBL4204115 0.83 ALDH1A1 (0.70) ALDH1A1HPGDHTTGAANPSR1
SCHEMBL14777290 0.82 KMT2A (0.59) ALDH1A1HPGDHTTNPSR1HSD17B10
SCHEMBL4206304 0.82 SMN1; SMN2 (0.57) ALDH1A1HPGDHTTHSD17B10NPC1
SCHEMBL6265130 0.75 PKM (0.56) ALDH1A1HPGDHTTHSD17B10SMN1; SMN2
SCHEMBL6265126 0.74 PKM (0.54) ALDH1A1HPGDHTTNPSR1HSD17B10
SCHEMBL6403696 0.74 PKM (0.55) ALDH1A1HPGDHTTNPSR1HSD17B10
SCHEMBL4204163 0.73 SMN1; SMN2 (0.57) ALDH1A1HTTNPSR1RAB9ASMN1; SMN2
SCHEMBL6404384 0.72 PKM (0.70) ALDH1A1HPGDHTTGAANPSR1
SCHEMBL4204703 0.72 SMN1; SMN2 (0.61) ALDH1A1HTTNPSR1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885HPGD 835/4885HTT 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.